AC Immune receives milestone in Anti-Tau Antibody collaboration with Genentech

13.July 2015 08:00 CET

English
Franšais
Deutsch

  • Lead candidate selected for further development towards clinical trials
  • Encouraging pre-clinical efficacy, safety and pharmacological properties